ID 109597
著者
ヒロセ, カヨ Department of Pharmacology, Institute of Health Biosciences, the University of Tokushima Graduate School|Department of Anesthesiology, Tokyo University Graduate School of Medicine
川人, 伸次 Department of Anesthesiology, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
箕田, 直治 Department of Anesthesiology, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
高石, 和美 Department of Dental Anesthesiology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
カワハラ, トミヤ Department of Anesthesiology, Tokushima University Hospital
曽我, 朋宏 Department of Anesthesiology, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
カタヤマ, トシコ Department of Anesthesiology, Tokushima University Hospital
居村, 暁 Department of Digestive and Pediatric Surgery, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
森根, 裕二 Department of Digestive and Pediatric Surgery, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
池本, 哲也 Department of Digestive and Pediatric Surgery, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
島田, 光生 Department of Digestive and Pediatric Surgery, Tokushima University Hospital 徳島大学 教育研究者総覧 KAKEN研究者をさがす
松久, 宗英 Diabetes Therapeutics and Research Center, the University of Tokushima 徳島大学 教育研究者総覧 KAKEN研究者をさがす
北畑, 洋 Department of Dental Anesthesiology, Institute of Health Biosciences, the University of Tokushima Graduate School 徳島大学 教育研究者総覧 KAKEN研究者をさがす
キーワード
insulinoma
perioperative glucose management
artificial endocrine pancreas
anesthetic management
continuous blood glucose monitoring
資料タイプ
学術雑誌論文
抄録
A 71-year-old woman had an episode of syncope due to hypoglycemia of 27 mg/dl. She was diagnosed with insulinoma and scheduled for laparoscopic enucleation along with the use of an artificial endocrine pancreas (STG-22, Nikkiso Co., Ltd., Tokyo, Japan). Anesthesia was maintained with sevoflurane and remifentanil. Her blood glucose level was controlled using the artificial endocrine pancreas, which enabled continuous blood glucose monitoring and computer-operated glucose and insulin infusion to maintain the blood glucose level at a steady state. The target concentration of blood glucose was set at 80-120 mg/dl during surgery. Until removal of the tumor, the blood glucose level was kept at around 80-100 mg/dl. After removal of the tumor, the blood glucose level gradually increased, but it was kept in the normal range by the artificial endocrine pancreas. The artificial endocrine pancreas was useful to monitor and maintain blood glucose levels during and after the removal of insulinoma, without any hyper- or hypoglycemia.
掲載誌名
The journal of medical investigation : JMI
ISSN
13431420
cat書誌ID
AA11166929
61
3-4
開始ページ
421
終了ページ
425
並び順
421
発行日
2014-08
EDB ID
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系
病院
先端酵素学研究所
歯学系